Facebook
Twitter
LinkedIn
Forward
2024 REDDI Lab Research Symposium
The Research and Education in Disease Diagnosis and Intervention (REDDI) Lab is Clemson University's high-complexity, CLIA-certified diagnostics laboratory that provides infectious disease testing, as well as other testing, to Clemson University and its surrounding communities. This year, the 4th Annual REDDI Lab Research Symposium will have a focus on broadening research and professional development in public health epidemiology, primarily with infectious disease, but also for other diseases including cancer, neurodegenerative diseases, and developmental disorders.
Target Audience
Primary Audience
- Practicing Physicians
- Fellows
- Residents
Secondary Audience
- Allied Health
- Medical Students
- Nurse Practitioners
- Registered Nurses
Specialty Audience
- ENT
- Family Medicine
- Infectious Disease
- Internal Medicine
- Oncology
- Pathology
- Radiation Oncology
Learning Objectives
As a result of participating in this learning activity, participants will...
- Have a better understanding of novel, innovative, and state-of-the-art research in public health epidemiology
- Know more about new and improved diagnostic and therapeutic methods for many types of diseases and disorders that should directly improve patient health outcomes
- Gain insight into the mitigation and suppression of infectious disease, as well as improving diagnostic testing efficiency.
Additional Information
| Attachment | Size |
|---|---|
 Credit Attestation Information | 86.61 KB |
| Ethos Instructions | 102.32 KB |
Time | Session |
| 11:00 AM – 12:00 PM | Arrival, Check-In, Poster Preparation |
Session #1 (12:00 PM - 2:00 PM) | |
| 12:00 PM – 12:10 PM | Event Introduction Opening Statement David Stefanich, MBA, MSc, MCA |
| 12:10 PM – 12:20 PM | “Let’s Get REDDI!” Delphine Dean, Ph.D. Lab Director, REDDI Lab |
| 12:20 PM - 12:50 PM | “Adapting for Accessibility and Affordability: Saliva as a Sample Type to Overcome Testing Barriers for Better Outbreak Control” Anne Wyllie, Ph.D. Assistant Professor, Yale University School of Public Health |
| 12:50 PM - 1:05 PM | Speaker #2 Precision Genetics |
| 1:05 PM - 1:15 PM | Coffee Break |
| 1:15 PM - 1:30 PM | “DNA Methylation ‘Episignature’ Testing for Neurodevelopmental Disorders: Introduction and Applications” Matt Tedder, Ph.D. Staff Scientist, Greenwood Genetic Center |
| 1:30 PM - 2:00 PM | “Disease Modeling and Analytics to Inform Outbreak Preparedness, Response, Intervention, Mitigation, and Elimination in South Carolina (DMA-Prime)” Lior Rennert, Ph.D. Associate Professor, Clemson University Department of Public Health |
| 2:00 PM - 3:00 PM | Networking and Poster Session |
Session #2 (3:00 PM - 5:15 PM) | |
| 3:00 PM - 3:30 PM | “Salivary Biomarkers: Revolutionizing Concussion Diagnostics and Patient Care” Carolyn Banister, Ph.D., SCT(ASCP)MBCM MLSCM Director, University of South Carolina Diagnostic Genomics Laboratory |
| 3:30 PM - 3:45 PM | “Web 3.0 Adoption in Global Health Initiatives” David Stefanich Rymedi, Inc. |
| 3:45 PM - 4:00 PM | “Detection of SARS-CoV-2: Reactive IgG in Pre-Pandemic Salivary Samples from South Carolina Emergency Healthcare Workers” Haley Meltzer Research Technician, University of South Carolina School of Medicine Greenville |
| 4:00 PM - 4:10 PM | Coffee Break |
| 4:10 PM - 4:40 PM | “Tackling Rogue Autoantibodies through Therapeutic Decoys” Prem Premsrirut, M.D., Ph.D. Chief Executive Officer, Micoy Therapeutics, Inc. |
| 4:40 PM - 5:00 PM | “Oral Microbiome and Dental Health as an Indicator for Predisposition to Respiratory Infectious Diseases” Congyue Annie Peng, Ph.D., M(ASCP) REDDI Lab, Clemson University |
| 5:00 PM - 5:30 PM | Open-Floor Panel Discussion Melissa Nolan, Ph.D., MPH Sarah Nickel, M.S., MLS(ASCP)CM |
| 5:30 PM - 5:40 PM | Closing Statements Austin Smothers, Ph.D. Director of Strategic Operations, REDDI Lab |
| 5:40 PM - 6:00 PM | Event Dismissal |
“The University of South Carolina School of Medicine Greenville has been reviewed by the Accreditation Council for Continuing Medical Education (ACCME®) and awarded Accreditation with Commendation as a provider of continuing medical education (CME) for physicians. Accreditation in the ACCME System seeks to assure the medical community and the public that the University of South Carolina School of Medicine Greenville delivers education that is relevant to clinicians’ needs, evidence-based, evaluated for its effectiveness, and independent of commercial influence.”
Available Credit
- 5.75 AMA PRA Category 1 Credit(s)™The University of South Carolina School of Medicine Greenville designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The University of South Carolina School of Medicine Greenville is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. - 5.75 Attendance